Editorial
Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?
Abstract
Nonalcoholic fatty liver disease (NAFLD) consists of a spectrum of disorders characterized predominantly by hepatic steatosis in the absence of significant alcohol consumption, potentially evolving to nonalcoholic steatohepatitis (NASH), with increased hepatocellular injury and inflammation with or without fibrosis.
